%0 Journal Article
%T TNF Inhibitor
%A Joseph F. Merola
%A Lourdes M. Perez-Chada
%A Sara Jiayang Li
%J Journal of Psoriasis and Psoriatic Arthritis
%@ 2475-5311
%D 2019
%R 10.1177/2475530318810851
%X Tumor necrosis factor ¦Á (TNF-¦Á)-targeted therapies have expanded the therapeutic options for patients with inflammatory bowel disease (IBD), rheumatoid arthritis (RA), psoriasis, and psoriatic arthritis (PsA) and have significantly improved patients¡¯ quality of life. Paradoxically, anti-TNF-¦Á agents may induce psoriatic eruptions or worsen preexisting psoriatic skin disease. Currently, there is no standard approach for the management of TNF inhibitor-induced psoriasis. Here, we conduct a literature review on TNF inhibitor-induced psoriasis and introduce a novel treatment algorithm for maintaining otherwise effective anti-TNF therapy versus switching to a different class as appropriate in the management of patients with IBD, RA, psoriasis, or PsA
%K TNF inhibitor-induced psoriasis
%K biologic agents
%K TNF-¦Á
%U https://journals.sagepub.com/doi/full/10.1177/2475530318810851